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Transforming growth factor-@ (TGFB) stimulated the 
production of total protein, collagen, and fibronectin 
by normal human lung fibroblasts. The stimulatory 
response was maximal at 100 p~ TGFP and reversed 
toward control at higher concentrations. Inhibition of 
fibroblast prostaglandin (PG) synthesis enhanced 
TGFB-induced stimulation of total protein, collagen, 
and fibronectin production and reversed the negative 
slope of the dose-response curve at high concentrations 
of TGFB. Determination of the steady-state  levels of 
Types I  and I11 procollagens and fibronectin mRNAs 
employing specific cDNA probes demonstrated that 
inhibition of fibroblast PG production increased the 
stimulatory effect of TGFB on the levels of these tran- 
scripts. Exogenous PGE, abrogated the stimulatory 
effects of TGFB. These findings suggest that fibroblast 
stimulation by TGFB may be down-regulated by endog- 
enous PG synthesized in response to TGFB. This notion 
was supported by the demonstration that TGFB mark- 
edly stimulated fibroblast PGE, production. These re- 
sults indicate that TGFB-induced stimulation of fibro- 
blast PGE, production may  be an autoregulatory con- 
trol mechanism to limit the effects of TGFB on 
connective tissue protein synthesis. 
The extracellular matrix of connective tissue consists of 
complex and highly organized macromolecules, including col- 
lagen and fibronectin. Synthesis of connective tissue compo- 
nents is necessary for maintenance of the structural and 
functional integrity of most parenchymal organs as well as 
for a variety of dynamic events such as wound healing, repair, 
and development. The  net accumulation of extracellular ma- 
trix is dependent on a precise balance between the synthesis 
and  the degradation of connective tissue components. Exces- 
sive deposition of collagen and fibronectin is characteristic of 
pathological states of fibrosis, including scleroderma and pul- 
monary fibrosis (1 ,2) .  Fibroblast connective tissue production 
must, therefore, be self-limited in order to prevent abnormal 
fibrogenesis. Thus, these cells must be responsive to both 
stimulatory  and  inhibitory influences. The frequent observa- 
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tion of a proximity of fibroblasts and chronic inflammatory 
cells in areas undergoing active fibrogenesis has suggested 
that cytokines may play an important role in modulation of 
fibroblast functions (3,  4). 
Transforming growth factor$ (TGFP),’ a polypeptide pro- 
duced by neoplastic and normal cells including macrophages 
and lymphocytes (5), has been shown to stimulate fibroblast 
protein, collagen, and fibronectin production in vitro (6-8) 
and  to accelerate wound healing and angiogenesis in experi- 
mental animals in vivo (9, 10). Fibroblasts cultured in the 
presence of TGFP display an increase in the steady-state 
levels of fibronectin and Types I  and I11 procollagen mRNAs 
(11-13), which remain elevated even after removal of TGFP 
from the culture medium (12). It therefore appears that TGFP 
can stimulate and perpetuate augmented connective tissue 
biosynthesis and may, thus, play a major  role in  the develop- 
ment of fibrosis. On the other  hand, fibroblast collagen and 
fibronectin production is inhibited by prostaglandins (PG) 
(14,15), suggesting that endogenous PG production by fibro- 
blasts may participate in the autocrine modulation of TGFP 
effects. To examine experimentally this hypothesis, we inves- 
tigated the effect of TGFP on lung fibroblast PGE, production 
and the influence of endogenous and exogenous PGE, on 
TGFP-stimulated  total  protein, collagen, and fibronectin syn- 
thesis by these cells. We found that TGFP markedly stimu- 
lated the production of PGE, by the fibroblasts and that  the 
stimulatory effects of TGFP on connective tissue production 
were further enhanced by inhibition of endogenous PGE, 
synthesis. Measurement of the steady-state levels of Types I 
and I11 procollagen and fibronectin mRNAs showed that 
inhibition of fibroblast prostaglandin production resulted in 
augmentation of the stimulatory effect of TGFP on the levels 
of these  transcripts. Endogenous and exogenous PGE, abro- 
gated the stimulatory effects of TGFP on collagen and fibro- 
nectin production. Our results indicate that under normal 
circumstances, endogenous PGE, may  play an important role 
in limiting or terminating the stimulation of fibroblast con- 
nective tissue synthesis induced by TGFP. 
MATERIALS  AND  METHODS 
Fibroblast Culture and Labeling Conditiom-Human lung fibro- 
blast cell lines were established using explant techniques from his- 
tologically normal areas of lungs surgically resected for diagnostic 
reasons. Early passage cells were seeded at a density of 5 X lo4 cells/ 
well in 24-well flat-bottom plates and cultured in Eagle’s minimal 
essential medium supplemented with 10% fetal calf serum and 1% 
vitamins, and incubated at 37 “C in 5% CO,. After the cultures 
reached confluency, the media were removed and fresh media con- 
taining 1% fetal calf serum, ascorbic acid (50 pg/ml), and various 
concentrations of PGE, (Sigma) and human TGFP (Collaborative 
Research Inc., Bedford, MA) were added to  the wells. Appropriate 
cultures were preincubated for 30 min with indomethacin (1 pg/ml). 
After 5  h, 0-aminopropionitrile (100 pg/ml) and 1.5 pCi/ml [U-14C] 
proline were added and  the incubation continued for 24 h. In some 
experiments, the factors were added every 24 h for 3 days and  the 
cultures were labeled for the last 20 h of incubation. A t  the end of 
the experiments, the media  were harvested and added to a solution 
containing a mixture of protease inhibitors to yield the following 
concentrations: 5 mM EDTA, 0.2 M phenylmethylsulfonyl fluoride, 5 
mM N-ethylmaleimide, 1 mM p-aminobenzamidine hydrochloride. 
Cell monolayers were washed twice with a cold solution of 0.15 M 
’ The abbreviations used are: TGFP, transforming growth factor- 
@; ELISA, enzyme-linked immunosorbent assay. 
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NaCl, 50 mM Tris-HC1, and protease  inhibitors, and  the cells were 
detached mechanically and  then sonicated in the same buffer. Control 
cultures were handled exactly as described above, except that  the 
culture media did not contain TGFB or PGE,.  All experiments were 
performed in  triplicate. 
Analysis of Lubeled Proteins and PGE, Assay-Aliquots of media 
and cell layers were exhaustively dialyzed to remove unincorporated 
radioactive precursors. Total incorporation of [U-'4C]proline into 
macromolecules was measured in  a  scintillation spectrophotometer. 
The amount of radioactive collagen synthesized by the fibroblasts 
was determined by a  bacterial collagenase assay (16) and  the relative 
proportion of collagen calculated following the formula of Breul et al. 
(17). The labeled proteins  in the media and cell layers were analyzed 
by electrophoresis on SDS-polyacrylamide slab gels (7%) under re- 
ducing conditions. After electrophoresis, the gels  were processed for 
fluorography, and the relative proportion of radioactivity in each 
band was determined by densitometric  scanning (540 nm). In  addi- 
tion, newly synthesized fibronectin was quantified by immunoprecip- 
itation with a specific anti-human fibronectin antibody (Bethesda 
Research Laboratories) as described previously (18). 
PGE, production by control and treated fibroblast cultures was 
determined by a specific ELISA assay of the undialyzed media (19) 
of confluent fibroblast cultures incubated with TGFp for 24 h as 
described. 
Isolation and Analysis of Total RNA from the Lung Fibroblasts- 
Lung fibroblasts were cultured in T-75 flasks in the presence or 
absence of 500 p~  TGFP and indomethacin as described above. At 
the  end of the incubation period the cell layers were washed in Hanks' 
solution and harvested  in  4 M guanidinium isothiocyanate, and  total 
RNA was isolated in a CsCl, discontinuous  gradient as described by 
Maniatis  et al. (20). For Northern blot analysis, aliquots of 10 pg  of 
total RNA were denatured  in formaldehyde, electrophoresed in 0.8% 
agarose gels, and  then transferred to nitrocellulose filters. Human 
cDNA clones Hf677 specific for d(1 )  procollagen (21), S318 specific 
for al(II1)  procollagen (a gift from Dr. Leena Ala-Kokko, Jefferson 
Institute of Molecular Medicine, Philadelphia,  PA), and  pFHl spe- 
cific for fibronectin (22) were nick-translated with [cY-~'P]~ATP  to a 
specific activity of 2.1 to 7.2 X lo-' dpm/pg as described by Rigby et 
al. (23). The filters were hybridized for 24 h in a 50% formamide 
solution. Autoradiographs were scanned with a densitometer. For 
quantitative  estimation of specific mRNA levels hybridized to each 
cDNA clone the integrated  areas were corrected for total RNA and 
of RNA hybridized/pg of RNA electrophoresed X total RNA/total 
DNA using the following equation: specific mRNA = integrated  area 
DNA as described (24). The  amount of DNA was quantified by a 
fluorimetric method (25). 
RESULTS 
Effect of Inhibition of Fibroblast PGE, Synthesis on the 
Stimulation of  Collagen and Fibronectin Production by 
TGFP-Treatment of lung fibroblasts with TGFp up to a 
concentration of 250 pM resulted in stimulation of total 
protein, collagen and  fibronectin production. At  higher TGFp 
concentrations, however, the amount of newly synthesized 
macromolecules declined toward control values (Table I, Fig. 
1, A and B ) .  To investigate the mechanisms responsible for 
this decline, we examined the effects of inhibition of endoge- 
nous lung fibroblast PG production by indomethacin. The 
rationale to perform these  experiments was the well known 
inhibitory effect of PGE, on fibroblast connective tissue bio- 
synthesis (14, 15). The addition of TGFp to cultures pre- 
treated with indomethacin resulted in progressive and  quan- 
titatively higher stimulation of fibroblast total  protein, colla- 
gen, and fibronectin production by TGFB concentrations of 
up to 500 PM (Table I, Fig. 1, A and B ) .  These effects on 
fibronectin production were confirmed by immunoprecipita- 
tion  (data  not shown). 
To examine if this finding was reproducible, we evaluated 
the response of four separate lung fibroblast cell lines to 
TGFP (500 PM) in the presence and absence of indomethacin 
(data not shown). TGFB in the absence of indomethacin 
caused stimulation of the production of total  protein, collagen, 
and fibronectin by three cell lines whereas a  fourth cell line 
showed a moderate decrease in collagen but  an increase in 
fibronectin production. Pretreatment of cultures with indo- 
methacin enhanced  TGFP effects in the three  stimulated cell 
lines and reversed the decrease in the fourth with a net 
stimulatory effect. 
Effect of TGFP on PGE, Production by the Fibroblasts- 
The finding of a negative slope on the dose-response curve of 
lung fibroblasts stimulated with high concentrations of TGFP 
in the absence of indomethacin suggested that TGFp at these 
concentrations might induce an endogenous inhibitor of col- 
lagen and fibronectin production by these cells. The restora- 
tion of a  stimulatory response to TGFP by preincubating the 
cultures with indomethacin indicated that  this inducible en- 
dogenous inhibitor might be a cyclooxygenase product. To 
confirm this possibility directly, the amount of PGE, in the 
media of control  and  TGFP-treated  cultures was measured by 
an ELISA. The addition of TGFp to  the cultures caused a 
dose-dependent stimulation in the synthesis of PGE,. Al- 
though a 4-fold increase in  the production of PGE, was noted 
at low doses of TGFP, dramatic stimulation was apparent 
when TGFP concentration exceeded 100 PM (Fig. IC). In a 
separate experiment, we tested if the  TGFP effect on PGE, 
production was saturable  and compared PGE, production by 
cultures exposed to 500 and 1000 PM TGFP. We found that 
TGFP at  a  concentration of 1000 pM did not cause further 
stimulation (62 f 1.3 versus 64 f 1.8 ng/ml). 
Effect of Exogenous PGE, on Collagen and Fibronectin Pro- 
duction by TGFP-treated Fibroblasts-To confirm that the 
diminished response to  TGFp by lung fibroblasts cultured in 
the absence of indomethacin was a consequence of endogenous 
PG  synthesis induced by TGFP, the effect of exogenous PGE, 
on collagen and fibronectin synthesis by cultures  treated with 
TGFp was examined. In  these experiments endogenous fibro- 
blast  PG production was  blocked by preincubation with in- 
domethacin. As shown in  Table 11, the addition of increasing 
concentrations of PGE, to  the cultures exposed to  TGFp plus 
indomethacin caused a reversal of TGFp effects. At  a concen- 
tration of  100 ng/ml of PGE,, the TGFP-induced stimulation 
of collagen and fibronectin production was almost completely 
abrogated. The amount of PGE, added to  the cultures (10- 
100 ng/ml) was in the range of that produced by the TGFP- 
treated fibroblasts. 
Effects of TGFP on Procollagen and Fibronectin mRNA 
Levels in the Presence and Absence of Indomethacin-In order 
to investigate the mechanism of augmentation of TGFP ef- 
fects on fibroblast collagen and fibronectin synthesis by cy- 
clooxygenase inhibition, the steady-state mRNA levels for 
al(1) and  al(II1) procollagens and fibronectin were examined 
by Northern blot hybridization using specific cDNA probes 
for these transcripts (Fig. 2). The autoradiographs of the 
Northern blots were quantified by densitometric analysis 
(Table 111). The results indicate that  TGFp caused a 3-fold 
increase in the amount of Type I  and Type I11 procollagen 
mRNAs and  a 5-fold increase in fibronectin mRNA. When 
endogenous PG synthesis was inhibited by the addition of 
indomethacin to  the cultures, TGFp caused a  further increase 
in the levels of these mRNAs. 
DISCUSSION 
In these experiments we found that TGFP induced a repro- 
ducible stimulation of the production of total  protein, colla- 
gen, and fibronectin by several cultured human lung fibroblast 
cell lines. Blockade of endogenous PG  synthesis with indo- 
methacin potentiated the stimulatory effect of TGFp  on  the 
production of these proteins. These findings suggested that 
PG may function to down-modulate the effects of TGFp on 
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TABLE I 
Effects of indomethacin on TGFP-induced stimulation of total protein, 
collagen, and fibronectin synthesis by lung fibroblasts 
Confluent human lung fibroblasts were incubated for 24 h with control medium or with media containing 
different  concentrations of TGFp with or without  indomethacin (1 pg/ml) and labeled with [U-“Clproline. The 
amount of newly synthesized total protein, collagen, and fibronectin  in the media and cell layers was determined 
as described under “Materials and Methods.” Values represent the average from triplicate experiments which 
varied less than 10% from each other. The numbers in parentheses show the percentage relative to control values. 
Total  protein Collagen Fibronectin 
Indomethacin  Indomethacin Indomethacin  Indomethacin Indomethacin  Indomethacin 
- + - + - + 
cpm X IO-3 cpm X cpm X 
Control 36.9  41.7  6.7  7.0  5.6  6.4 
TGFB 
10 pM 35.4  (95) 48.6  (116) 8.0  (119) 11.6  (165) 8.1  (144)  10.0 (156) 
50 PM 43.0  (116) 60.9  (146) 12.0  (179) 15.6  (222) 11.2  (200) 
100 pM 59.2  (160) 68.7  (164) 13.5  (201) 16.0  (228) 11.9  (212)  7.6 (275) 
250 PM 56.5  (153) 72.4  (173) 13.9  (207) 19.0  (271) 14.1  (251)  9.2 (300) 
500 p M  48.1  (130) 79.2  (190) 11.3  (168) 19.7  (281) 9.7  (1 3)  21.5 (336) 
Concentration of TGF-P [pM] 
FIG. 1. Effects of indomethacin  on TGFB stimulation of col- 
lagen, fibronectin, and PGE, production by lung fibroblast 
cultures. Confluent human lung fibroblasts were incubated with 
varying concentrations of TGFp  in  the presence or absence of indo- 
methacin (1 pg/ml) for 24 h and labeled with [U-’‘C]proline as 
described under  “Materials and Methods.” The  amounts of radioac- 
tivity in newly synthesized collagen were determined by a specific 
bacterial collagenase assay (16) and those  in fibronectin by densito- 
metric analysis of fluorographs. The levels of PGE, in  the media were 
measured by an ELISA (19). A, newly synthesized collagen; B, newly 
synthesized fibronectin; C, PGE, levels. M, cultures incubated 
in  the presence of indomethacin; M, cultures  incubated in  the 
absence of indomethacin. 
collagen and fibronectin production. When higher concentra- 
tions of TGFP (250 and 500 PM) were used, the dose-response 
curve of the production of these  proteins displayed a down- 
ward  slope. Furthermore, the potentiation of this  TGFP effect 
by indomethacin was much more pronounced at  high TGFP 
concentrations. These findings suggested that  the higher con- 
centrations of TGFP resulted in the production of an endog- 
TABLE I1 
Effect of the addition of exogenous PGE,  on total protein, collagen, 
and fibronectin production by TGFB- or TGFB plus indomethacin 
(IND)-treated cultures 
Confluent human lung fibroblasts were incubated in  triplicate for 
24 h with control medium or with media containing 500 PM TGFB, 1 
pg/ml indomethacin, and either 10 or 100 ng/ml PGE,. Following 
labeling with [U-14C]proline, the media and cell layers were processed 
as described under  “Materials and Methods.” 
Total Drotein Collaeen Fibronectin 
cpm X cpm X  IO-^ cpm X 
Control 
IND 
36.9  6.7  5.6 
TGFB 
41.7  7.0 6.4 
TGFB + IND 
48.1  11.3 9.7 
79.2  19.7 
TGFB + IND + 
21.5 
47.5  10.5 8.1 
TGFp + IND + 40.9  9.8  6.2 
10 ng/ml PGE, 
100 ng/ml PGE, 
7.9 kb- 
5.8 kb- 
4.8 kb- 
H, 667 S 318 pFH 1 
1 2 3 4   1 2 3 4   1 2 3 4  
FIG. 2. Northern  blot  hybridization analysis of steady-state 
mRNA levels for al(1) and al(II1) procollagens and fibronec- 
tin in  fibroblasts  treated with TGFB and  indomethacin. Con- 
fluent human lung fibroblasts were incubated for 24 h in Eagle’s 
minimal essential medium/l% FCS alone (lane 1 )  or with 1 pg/ml 
indomethacin (lane 2 ) ,  500 PM TGFp (lane 3 ) ,  or 500 pM TGFB plus 
1 pg/ml indomethacin (lane 4 ) .  Total RNA was extracted from each 
culture as described under  “Materials and Methods,” and after de- 
naturation, samples containing 10 pg of RNA were electrophoresed 
in each lane of 0.8% agarose gels and transferred to nitrocellulose 
filters. The filters were hybridized to radiolabeled human cDNA 
probes specific for pro-al(1) collagen (Hf677), pro-al(II1) collagen 
(S318), and fibronectin (pFH1). 
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TABLE I11 
Densitometric  analysis of total RNA from TGFP- and indomethacin 
(ZND)-treated lung fibrobhts hybridized to procollagen al(Z), 
procollagen al(III) ,  and  fibronectin cDNA clones 
Northern blot autoradiographs shown in Fig. 2 were scanned with 
a  densitometer and  the  areas quantified employing a planimeter. The 
values of integrated  areas were corrected for the  total yield of RNA 
and DNA according to  the equation: specific mRNA = integrated 
area of RNA hybridized/pg of RNA electrophoresed X total RNA/ 
total DNA and  are expressed as a -fold increase relative to control. 
Pro-al(1)  l II1) Fibronectin 
Control 1 .oo 1.00 
IND 
1.00 
1 .oo 
TGFB 
1.39 1.03 
3.71 3.85 5.64 
TGFp + IND 5.77 5.38 6.60 
enous inhibitory factor which reversed the stimulatory effect 
of TGFP  on collagen and  fibronectin production. This inhib- 
itory activity was completely abolished by pretreatment of 
cultures with indomethacin. The addition of exogenous PGE, 
in  the range of concentrations produced by the fibroblasts 
abrogated the TGFP  stimulation of collagen and fibronectin 
production. Furthermore, the measurement of PGE, levels in 
the media of cultures treated with TGFP showed a dose- 
dependent increase in fibroblast  PG production. These obser- 
vations suggest that the marked elevation in PGE, levels 
induced by high concentrations of TGFP was responsible for 
the negative portion of the TGFP dose-response curve of 
collagen and fibronectin production. In addition, our obser- 
vation that in some cell lines pretreatment with indomethacin 
permitted the expression of the stimulatory effect of TGFP 
on collagen synthesis implicated TGFP-induced endogenous 
prostaglandin production as a possible explanation for the 
variable response to TGFP occasionally noted by us  and  others 
(11, 12). 
The levels of mRNAs for al(1) and al(II1) procollagens 
and for fibronectin were increased in TGFP-treated lung 
fibroblasts. The TGFP-induced elevation of the levels of these 
transcripts was increased further when endogenous PG pro- 
duction was inhibited by indomethacin. These findings pro- 
vide evidence that  the down-regulation of collagen and fibro- 
nectin production in  TGFP-treated fibroblasts by endogenous 
PGE occurs largely at  a  pretranslational level. 
Our results suggest that the stimulation of endogenous 
fibroblast PGE, production by TGFP may serve as  a negative 
feedback mechanism to limit the increase in extracellular 
matrix  protein production induced by this cytokine. Similar 
autocrine modulation of collagen biosynthesis mediated by 
endogenous PG  has been demonstrated in fibroblasts stimu- 
lated with bradykinin (26) and interleukin 1 (27). The obser- 
vations described in  this paper raise the possibility that  en- 
dogenous fibroblast PG may play a role in limiting the  stim- 
ulation of extracellular matrix  proteins deposition induced by 
TGFP in vivo. A derangement in this autocrine regulatory 
mechanism could contribute to  the initiation or progression 
of pathological states characterized by fibrosis. 
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